Bold Insight tackles pediatric cancer journeys with UX research expertise
Posted:
Philanthropy is central to Bold Insight’s mission, driving the commitment to improving how humans interact with products and services around the world. Read the full article here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us